GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » hVIVO PLC (LSE:HVO) » Definitions » Float Percentage Of Total Shares Outstanding

hVIVO (LSE:HVO) Float Percentage Of Total Shares Outstanding : 0.00% (As of Jun. 11, 2024)


View and export this data going back to 2012. Start your Free Trial

What is hVIVO Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, hVIVO's float shares is 0.00 Mil. hVIVO's total shares outstanding is 680.37 Mil. hVIVO's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, hVIVO's Insider Ownership is 7.08%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, hVIVO's Institutional Ownership is 13.66%.

hVIVO Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

hVIVO's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/680.37
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

hVIVO (LSE:HVO) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » hVIVO PLC (LSE:HVO) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
LSE:ARIX LSE:SCLP LSE:FUM LSE:REDX LSE:FARN LSE:OBD LSE:BVXP LSE:4BB LSE:ETX LSE:AREC OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
OPORF:USA HVO:Ireland ORPH:UK CRO:Germany
Address
42, New Road, Queen Mary Bioenterprises Innovation Centre, London, GBR, E1 2AX
Website
https://www.hvivo.com
hVIVO PLC is a European-focused, rare, and orphan drug consulting services platform. The principal activity of the Group is that of a rapidly growing specialist CRO pharmaceutical services company, which involves the testing of vaccines and antivirals using human-challenge clinical trials. The group is also engaged in Venn Life Sciences' Clinical Research Division, providing a suite of consulting and clinical trial services to pharmaceutical, biotechnology, and medical device organizations.

hVIVO (LSE:HVO) Headlines

No Headlines